Sanofi Expands Its Cancer Drug Pipeline Through $1 Billion Amunix Purchase

By PacConAdmin | December 21, 2021

In a purchase aimed at broadening its portfolio of cancer therapies, Sanofi is acquiring San Francisco, Calif.-based Amunix Pharmaceuticals for $1 billion.
Source: Drug Industry Daily

Posted in Drug Industry Daily